UDG.L Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 янв. 1970 @ 03:00):

Stats
Объем за сегодня	3.14M
Средний объем	2.82M
Рыночная капитализация	0.00
EPS	£0.0573 ( 2019-06-29 )
Last Dividend	£0.125 ( 2021-01-07 )
Next Dividend	£0 ( N/A )
P/E	0.420
ATR14	£0 (0.00%)

UDG Healthcare plc Корреляция

10 Самые положительные корреляции

10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

UDG Healthcare plc Финансовые показатели

Annual	2020
Выручка:	£1.28B
Валовая прибыль:	£394.83M (30.87 %)
EPS:	£0.373

FY	2020
Выручка:	£1.28B
Валовая прибыль:	£394.83M (30.87 %)
EPS:	£0.373

FY	2019
Выручка:	£1.30B
Валовая прибыль:	£371.14M (28.58 %)
EPS:	£0.231

FY	2018
Выручка:	£1.32B
Валовая прибыль:	£381.60M (29.02 %)
EPS:	£0.0153

Financial Reports:

No articles found.

UDG Healthcare plc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)

UDG Healthcare plc Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.26 - Potential for dividend initiation, but uncertain (5.20%)

Information

First Dividend	£0.00468	1990-01-29
Last Dividend	£0.125	2021-01-07
Next Dividend	£0	N/A
Payout Date	2021-02-05
Next Payout Date	N/A
# dividends	63	--
Total Paid Out	£1.931	--
Avg. Dividend % Per Year	0.00%	--
Score	4.03	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	5.26
Div. Directional Score	8.01	--

Next Divdend (Est)
(2024-06-21)

£0 Estimate 0.00 %

Dividend Stability

0.09 Very Bad

Dividend Score

4.03

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield
1990	£0	0.00%
1991	£0	0.00%
1992	£0	0.00%
1993	£0	0.00%
1994	£0	0.00%
1995	£0	0.00%
1996	£0	0.00%
1997	£0	0.00%
1998	£0	0.00%
1999	£0	0.00%
2000	£0	0.00%
2001	£0	0.00%
2002	£0	0.00%
2003	£0	0.00%
2004	£0	0.00%
2005	£0	0.00%
2006	£0	0.00%
2007	£0	0.00%
2008	£0	0.00%
2009	£0	0.00%
2010	£0	0.00%
2011	£0	0.00%
2012	£0	0.00%
2013	£0	0.00%
2014	£0	0.00%
2015	£0	0.00%
2016	£0	0.00%
2017	£0	0.00%
2018	£0	0.00%
2019	£0	0.00%
2020	£0.168	0.02%
2021	£0.125	0.02%
2022	£0	0.00%
2023	£0	0.00%
2024	£0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for LSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SOLI.L	Dividend Knight	2023-09-07	Semi-Annually	29	1.07%
IVPU.L	Dividend Knight	2023-07-20	Quarterly	18	2.34%
BSC.L	Dividend Knight	2023-10-05	Semi-Annually	20	5.24%
PHAR.L	Dividend Junior	2023-06-15	Sporadic	12	1.15%
FORT.L	Dividend Knight	2023-09-21	Annually	9	3.03%
ABD.L	Dividend Junior	2023-08-10	Semi-Annually	35	0.96%
TEP.L	Dividend Knight	2023-07-20	Semi-Annually	25	2.14%
LGEN.L	Dividend Knight	2023-08-24	Semi-Annually	32	4.61%
CHRT.L	Dividend Knight	2023-08-24	Semi-Annually	19	1.43%
REL.L	Dividend Knight	2023-08-03	Semi-Annually	32	1.59%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0726	1.500	8.55	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0526	1.200	8.25	9.90	[0 - 0.3]
returnOnEquityTTM	0.0986	1.500	-0.0160	-0.0240	[0.1 - 1]
payoutRatioTTM	0.453	-1.000	5.47	-5.47	[0 - 1]
currentRatioTTM	1.919	0.800	5.41	4.32	[1 - 3]
quickRatioTTM	0.791	0.800	-0.0553	-0.0442	[0.8 - 2.5]
cashRatioTTM	0.791	1.500	6.72	10.00	[0.2 - 2]
debtRatioTTM	0.167	-1.500	7.22	-10.00	[0 - 0.6]
interestCoverageTTM	8.87	1.000	7.83	7.83	[3 - 30]
operatingCashFlowPerShareTTM	0.926	2.00	9.69	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.774	2.00	9.61	10.00	[0 - 20]
debtEquityRatioTTM	0.299	-1.500	8.81	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.309	1.000	8.19	8.19	[0.2 - 0.8]
operatingProfitMarginTTM	0.0995	1.000	-0.0102	-0.0102	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.785	1.000	6.75	6.75	[0.2 - 2]
assetTurnoverTTM	0.725	0.800	8.50	6.80	[0.5 - 2]
Total Score				10.75

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	36.30	1.000	6.43	0	[1 - 100]
returnOnEquityTTM	0.0986	2.50	-0.0103	-0.0240	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.774	2.00	9.74	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.926	2.00	9.69	10.00	[0 - 30]
payoutRatioTTM	0.453	1.500	5.47	-5.47	[0 - 1]
pegRatioTTM	47.57	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.180	1.000	7.99	0	[0.1 - 0.5]
Total Score				5.26

UDG Healthcare plc

UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates in two segments, Ashfield and Sharp. The Ashfield segment offers commercialization services for the pharmaceutical and healthcare industry in the areas of advisory, communications, and commercial and clinical services. This segment supports healthcare professionals and patients at various stages of the product life cycle; and provides field and contact center sales teams, healthcare communications, patient support, audit, advisory, medical information, and event management services to approximately 300 healthcare companies. The Sharp segment provides contract and clinical trial packaging services for the pharmaceutical and biotechnology industries; serialization solutions; and clinical IRT services. The company was formerly known as United Drug plc and changed its name to UDG Healthcare plc in August 2013. UDG Healthcare plc was founded in 1948 and is based in Dublin, the Republic of Ireland.